SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-13-233692
Filing Date
2013-05-24
Accepted
2013-05-23 17:38:45
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A d507513ds1a.htm S-1/A 910821
2 EX-1.1 d507513dex11.htm EX-1.1 96069
3 EX-3.1(B) d507513dex31b.htm EX-3.1.B 62947
4 EX-4.3 d507513dex43.htm EX-4.3 73412
5 EX-5.1 d507513dex51.htm EX-5.1 10208
6 EX-23.1 d507513dex231.htm EX-23.1 2545
7 GRAPHIC g507513g44a41.jpg GRAPHIC 32201
8 GRAPHIC g507513g57k06.jpg GRAPHIC 33709
9 GRAPHIC g507513g74f90.jpg GRAPHIC 24159
10 GRAPHIC g507513g90q05.jpg GRAPHIC 17579
  Complete submission text file 0001193125-13-233692.txt   1306083
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-187508 | Film No.: 13869527
SIC: 2835 In Vitro & In Vivo Diagnostic Substances